Efficacy and safety study of QAW039 in the treatment of patients with moderate to severe atopic dermatitis

Mise à jour : Il y a 4 ans
Référence : EUCTR2012-005321-78

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to determine whether QAW039 is safe and has beneficial effects in people who have moderate to severe atopic dermatitis (AD) - Eczema Area and Severity Index (EASI) score in comparison to placebo - Number of Participants with Adverse Events to assess Safety and tolerability


Critère d'inclusion

  • Atopic dermatitis